Boothbay Fund Management, LLC Y M Abs Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.27 Billion
- Q4 2024
A detailed history of Boothbay Fund Management, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 693,693 shares of YMAB stock, worth $3.97 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
693,693
Previous 557,429
24.45%
Holding current value
$3.97 Million
Previous $7.32 Million
25.8%
% of portfolio
0.17%
Previous 0.2%
Shares
9 transactions
Others Institutions Holding YMAB
# of Institutions
113Shares Held
26.9MCall Options Held
5.6KPut Options Held
900-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$24.2 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$16.8 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.86MShares$16.4 Million12.11% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$12.6 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$11.4 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $250M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...